Assessment of post-COVID-19 fatigue among female survivors 2 years after hospital discharge: a nested case–control study
Abstract Background Fatigue is a common symptom of long COVID syndrome. Compared to male survivors, females have a higher incidence of post-COVID fatigue. Therefore, long-term follow-up is necessary to understand which groups of females are more vulnerable to post-COVID fatigue. Methods This is a nested case–control study of female COVID-19 survivors who were discharged from two designated hospitals in Wuhan, China in 2020, and received 2-year follow-up from March 1 to April 6, 2022. All patients completed the Checklist Individual Strength-subscale subjective fatigue (CIS-fatigue), a chronic obstructive pulmonary disease (COPD) assessment test (CAT), and the Hospital Anxiety and Depression Scale (HADS; including the HADS-Anxiety [HADS-A] and the HADS-Depression [HADS-D]). Individuals with CIS-fatigue scores of 27 or higher were classified as cases. The risk factors for fatigue was analysed with multivariable logistic regression analysis. Results A total of 899 female COVID-19 survivors were enrolled for analysis, including 47 cases and 852 controls. Compared with controls, cases had higher CAT, HADS-A and HADS-D scores, and showed a higher prevalence of symptoms, including anxiety (cases vs. controls, 44.7% vs. 4.0%, p < 0.001), chest tightness (21.2% vs. 2.3%, p < 0.001), dyspnoea (19.1% vs. 0.8%, p < 0.001) and so on. In multivariable logistic regression analysis, age (OR, 1.03; 95% CI, 1.01–1.06; p = 0.02) and cerebrovascular disease (OR, 11.32; 95% CI, 2.87–43.00; p < 0.001) were risk factors for fatigue. Fatigue had a statistically significant moderate correlation with depression (r = 0.44, p < 0.001), but not with CAT ≥ 10. Conclusion Female COVID-19 patients who had cerebrovascular disease and older age have higher risk of fatigue. Patients with fatigue have higher CAT scores, and are more likely to have concurrent depression..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
BMC Public Health - 23(2023), 1, Seite 9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yidan Ye [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
doi: |
10.1186/s12889-023-17382-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ099869500 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ099869500 | ||
003 | DE-627 | ||
005 | 20240414060545.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240414s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12889-023-17382-0 |2 doi | |
035 | |a (DE-627)DOAJ099869500 | ||
035 | |a (DE-599)DOAJ48689073fddf4d03b669dc197c84f01c | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RA1-1270 | |
100 | 0 | |a Yidan Ye |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of post-COVID-19 fatigue among female survivors 2 years after hospital discharge: a nested case–control study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Background Fatigue is a common symptom of long COVID syndrome. Compared to male survivors, females have a higher incidence of post-COVID fatigue. Therefore, long-term follow-up is necessary to understand which groups of females are more vulnerable to post-COVID fatigue. Methods This is a nested case–control study of female COVID-19 survivors who were discharged from two designated hospitals in Wuhan, China in 2020, and received 2-year follow-up from March 1 to April 6, 2022. All patients completed the Checklist Individual Strength-subscale subjective fatigue (CIS-fatigue), a chronic obstructive pulmonary disease (COPD) assessment test (CAT), and the Hospital Anxiety and Depression Scale (HADS; including the HADS-Anxiety [HADS-A] and the HADS-Depression [HADS-D]). Individuals with CIS-fatigue scores of 27 or higher were classified as cases. The risk factors for fatigue was analysed with multivariable logistic regression analysis. Results A total of 899 female COVID-19 survivors were enrolled for analysis, including 47 cases and 852 controls. Compared with controls, cases had higher CAT, HADS-A and HADS-D scores, and showed a higher prevalence of symptoms, including anxiety (cases vs. controls, 44.7% vs. 4.0%, p < 0.001), chest tightness (21.2% vs. 2.3%, p < 0.001), dyspnoea (19.1% vs. 0.8%, p < 0.001) and so on. In multivariable logistic regression analysis, age (OR, 1.03; 95% CI, 1.01–1.06; p = 0.02) and cerebrovascular disease (OR, 11.32; 95% CI, 2.87–43.00; p < 0.001) were risk factors for fatigue. Fatigue had a statistically significant moderate correlation with depression (r = 0.44, p < 0.001), but not with CAT ≥ 10. Conclusion Female COVID-19 patients who had cerebrovascular disease and older age have higher risk of fatigue. Patients with fatigue have higher CAT scores, and are more likely to have concurrent depression. | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a Fatigue | |
650 | 4 | |a Female | |
650 | 4 | |a HADS | |
650 | 4 | |a SARS-CoV-2 | |
653 | 0 | |a Public aspects of medicine | |
700 | 0 | |a Chuyue Xiong |e verfasserin |4 aut | |
700 | 0 | |a Yang Dai |e verfasserin |4 aut | |
700 | 0 | |a Yan Wang |e verfasserin |4 aut | |
700 | 0 | |a Xinyue Yang |e verfasserin |4 aut | |
700 | 0 | |a Lixia Cheng |e verfasserin |4 aut | |
700 | 0 | |a Chao Hou |e verfasserin |4 aut | |
700 | 0 | |a Naifu Nie |e verfasserin |4 aut | |
700 | 0 | |a Huan Tang |e verfasserin |4 aut | |
700 | 0 | |a Xiangyu Ma |e verfasserin |4 aut | |
700 | 0 | |a Anqiang Zhang |e verfasserin |4 aut | |
700 | 0 | |a Guoqiang Cao |e verfasserin |4 aut | |
700 | 0 | |a Yong He |e verfasserin |4 aut | |
700 | 0 | |a Ji Jiang |e verfasserin |4 aut | |
700 | 0 | |a Li Li |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t BMC Public Health |d BMC, 2003 |g 23(2023), 1, Seite 9 |w (DE-627)DOAJ000057509 |x 14712458 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g pages:9 |
856 | 4 | 0 | |u https://doi.org/10.1186/s12889-023-17382-0 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/48689073fddf4d03b669dc197c84f01c |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1186/s12889-023-17382-0 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1471-2458 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 1 |h 9 |